David First Receives Stock Award at SQZ Biotechnologies Co (SQZ) — SEC Form 4, Feb 15, 2022
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
3 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| David First CIK 0001767296 |
Officer
|
David First at SQZ Biotechnologies Co
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at SQZ Biotechnologies Co
| 2023-01-26 | Award | — | View |
| 2021-02-25 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $6.57 | 2022-02-10 | A - Award/Grant | 66,000 A | $0.00 | 2032-02-09 | 66,000 Common Stock | Direct |
Footnotes (1)
- F1
- The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter. Show more
Related filings at SQZ Biotechnologies Co
Other insiders at SQZ Biotechnologies Co
GET /v1/forms/4/0001209191-22-009834
API docs
View Original SEC Filing